240 related articles for article (PubMed ID: 19147541)
21. Rapamycin and UCN-01 synergistically induce apoptosis in human leukemia cells through a process that is regulated by the Raf-1/MEK/ERK, Akt, and JNK signal transduction pathways.
Hahn M; Li W; Yu C; Rahmani M; Dent P; Grant S
Mol Cancer Ther; 2005 Mar; 4(3):457-70. PubMed ID: 15767555
[TBL] [Abstract][Full Text] [Related]
22. 37LRP induces invasion in hypoxic lung adenocarcinoma cancer cells A549 through the JNK/ERK/c-Jun signaling cascade.
Zhou Y; Wang Y; Zhao Z; Wang Y; Zhang N; Zhang H; Liu L
Tumour Biol; 2017 Jun; 39(6):1010428317701655. PubMed ID: 28618937
[TBL] [Abstract][Full Text] [Related]
23. Endothelin-1 stimulates preadipocyte growth via the PKC, STAT3, AMPK, c-JUN, ERK, sphingosine kinase, and sphingomyelinase pathways.
Siao AC; Lin YY; Shih LJ; Tsuei YW; Chuu CP; Kuo YC; Kao YH
Am J Physiol Cell Physiol; 2020 Nov; 319(5):C839-C857. PubMed ID: 32755450
[TBL] [Abstract][Full Text] [Related]
24. Epicatechin gallate induces cell death via p53 activation and stimulation of p38 and JNK in human colon cancer SW480 cells.
Cordero-Herrera I; MartÃn MA; Bravo L; Goya L; Ramos S
Nutr Cancer; 2013; 65(5):718-28. PubMed ID: 23859040
[TBL] [Abstract][Full Text] [Related]
25. Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK.
Bu HQ; Liu DL; Wei WT; Chen L; Huang H; Li Y; Cui JH
Oncol Rep; 2014 Feb; 31(2):975-82. PubMed ID: 24297112
[TBL] [Abstract][Full Text] [Related]
26. Opposing roles of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase in the cellular response to ionizing radiation in human cervical cancer cells.
Kim MJ; Choi SY; Park IC; Hwang SG; Kim C; Choi YH; Kim H; Lee KH; Lee SJ
Mol Cancer Res; 2008 Nov; 6(11):1718-31. PubMed ID: 19010820
[TBL] [Abstract][Full Text] [Related]
27. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2.
Xiao D; Choi S; Johnson DE; Vogel VG; Johnson CS; Trump DL; Lee YJ; Singh SV
Oncogene; 2004 Jul; 23(33):5594-606. PubMed ID: 15184882
[TBL] [Abstract][Full Text] [Related]
28. c-Jun N-terminal kinase contributes to apoptotic synergy induced by tumor necrosis factor-related apoptosis-inducing ligand plus DNA damage in chemoresistant, p53 inactive mesothelioma cells.
Vivo C; Liu W; Broaddus VC
J Biol Chem; 2003 Jul; 278(28):25461-7. PubMed ID: 12707267
[TBL] [Abstract][Full Text] [Related]
29. JNK/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts.
Ikeda F; Matsubara T; Tsurukai T; Hata K; Nishimura R; Yoneda T
J Bone Miner Res; 2008 Jun; 23(6):907-14. PubMed ID: 18251700
[TBL] [Abstract][Full Text] [Related]
30. Roles of mitogen-activated protein kinase pathways during Escherichia coli-induced apoptosis in U937 cells.
Wang JH; Zhou YJ; He P; Chen BY
Apoptosis; 2007 Feb; 12(2):375-85. PubMed ID: 17191113
[TBL] [Abstract][Full Text] [Related]
31. An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase.
Li G; Xiang Y; Sabapathy K; Silverman RH
J Biol Chem; 2004 Jan; 279(2):1123-31. PubMed ID: 14570908
[TBL] [Abstract][Full Text] [Related]
32. Role of p38 and JNK MAPK signaling pathways and tumor suppressor p53 on induction of apoptosis in response to Ad-eIF5A1 in A549 lung cancer cells.
Taylor CA; Zheng Q; Liu Z; Thompson JE
Mol Cancer; 2013 May; 12():35. PubMed ID: 23638878
[TBL] [Abstract][Full Text] [Related]
33. Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.
Mondal S; Mandal C; Sangwan R; Chandra S; Mandal C
Mol Cancer; 2010 Sep; 9():239. PubMed ID: 20836852
[TBL] [Abstract][Full Text] [Related]
34. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
[TBL] [Abstract][Full Text] [Related]
35. Involvement of c-jun NH(2)-terminal kinases in resveratrol-induced activation of p53 and apoptosis.
She QB; Huang C; Zhang Y; Dong Z
Mol Carcinog; 2002 Apr; 33(4):244-50. PubMed ID: 11933078
[TBL] [Abstract][Full Text] [Related]
36. ERK1/2 activation modulates pyocyanin-induced toxicity in A549 respiratory epithelial cells.
Forbes A; Davey AK; Perkins AV; Grant GD; McFarland AJ; McDermott CM; Anoopkumar-Dukie S
Chem Biol Interact; 2014 Feb; 208():58-63. PubMed ID: 24316274
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
Wu W; Pew T; Zou M; Pang D; Conzen SD
J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693
[TBL] [Abstract][Full Text] [Related]
38. Selective induction of apoptosis in mutant p53 premalignant and malignant cancer cells by PRIMA-1 through the c-Jun-NH2-kinase pathway.
Li Y; Mao Y; Brandt-Rauf PW; Williams AC; Fine RL
Mol Cancer Ther; 2005 Jun; 4(6):901-9. PubMed ID: 15956247
[TBL] [Abstract][Full Text] [Related]
39. c-Jun N-terminal kinase binding domain-dependent phosphorylation of mitogen-activated protein kinase kinase 4 and mitogen-activated protein kinase kinase 7 and balancing cross-talk between c-Jun N-terminal kinase and extracellular signal-regulated kinase pathways in cortical neurons.
Repici M; Mare L; Colombo A; Ploia C; Sclip A; Bonny C; Nicod P; Salmona M; Borsello T
Neuroscience; 2009 Mar; 159(1):94-103. PubMed ID: 19135136
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2.
Xu C; Yuan X; Pan Z; Shen G; Kim JH; Yu S; Khor TO; Li W; Ma J; Kong AN
Mol Cancer Ther; 2006 Aug; 5(8):1918-26. PubMed ID: 16928811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
